Advance in the pathogenesis and treatment of Wilson disease.
about
Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassayExtracellular matrix and liver diseaseWilson's disease: a comprehensive review of the molecular mechanisms.Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid.Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort.Protection of curcumin against amyloid-β-induced cell damage and death involves the prevention from NMDA receptor-mediated intracellular Ca2+ elevation.Charge regulation phenomenon predicted from the modeling of polypeptide electrophoretic mobilities as a relevant mechanism of amyloid-beta peptide oligomerization.Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors.Insights into the management of Wilson's disease.Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice.Molecular perception of interactions between bis(7)tacrine and cystamine-tacrine dimer with cholinesterases as the promising proposed agents for the treatment of Alzheimer's disease.Will formal genetics become dispensable?Nanomedicine: action of metal nanoparticles on neuronal nitric oxide synthase-fluorimetric analysis on the mechanism for fibrillogenesis.Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway.The Protective Role of Sulfated Polysaccharides from Green Seaweed Udotea flabellum in Cells Exposed to Oxidative Damage.
P2860
Q24313479-B7C063E9-AB8A-450B-BBE6-7922673012C0Q26823060-DA3850B2-3EEE-4A57-B1D0-3958D324A51FQ35381754-6319898A-AF94-4DE9-80D8-E9BCAC90F776Q38113683-2C19E1B8-B207-4567-AAC4-37F439112F27Q38269095-D57077D0-666E-408A-8983-1C21C80EB0DBQ38603323-24EFD23A-184C-4133-A772-8D7460B2503BQ38866324-D3AF3CDA-D7D1-4421-9E1F-B059DC5D96B7Q38926076-F1DD4054-83E3-4449-9664-59DA159EFB40Q39829425-EED77FA1-152A-4B70-9793-71F86495BFA2Q47105991-15AE5C79-2A12-41BA-9338-2E58BC87A2DDQ47106191-0BE9562A-04AE-4314-A6A7-844283BE6537Q48144788-355703CF-9B77-4EEE-9B11-44597708642AQ48155498-43E92687-157D-492F-854E-12413E35C798Q52645856-DAD6F54D-080E-476D-B09E-2424FD80C1A2Q54399278-D049BBC1-F372-40CC-9FE6-D46D5480606AQ54942367-623670D0-8506-4D7F-BBC5-C0A108311929
P2860
Advance in the pathogenesis and treatment of Wilson disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Advance in the pathogenesis and treatment of Wilson disease.
@ast
Advance in the pathogenesis and treatment of Wilson disease.
@en
type
label
Advance in the pathogenesis and treatment of Wilson disease.
@ast
Advance in the pathogenesis and treatment of Wilson disease.
@en
prefLabel
Advance in the pathogenesis and treatment of Wilson disease.
@ast
Advance in the pathogenesis and treatment of Wilson disease.
@en
P2860
P356
P1476
Advance in the pathogenesis and treatment of Wilson disease.
@en
P2093
Qin-Yun Dong
Zhi-Ying Wu
P2860
P2888
P356
10.1186/2047-9158-1-23
P577
2012-11-27T00:00:00Z
P5875
P6179
1043662777